Nicholas Company’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $41.9M | Buy |
982,444
+241,170
| +33% | +$13.1M | 0.77% | 47 |
|
|
2026
Q1 | $46.5M | Buy |
741,274
+114,116
| +18% | +$9.13M | 0.91% | 43 |
|
|
2025
Q4 | $59.8M | Hold |
627,158
| – | – | 1.05% | 33 |
|
|
2025
Q3 | $61.2M | Hold |
627,158
| – | – | 1.04% | 32 |
|
|
2025
Q2 | $67.4M | Hold |
627,158
| – | – | 1.13% | 31 |
|
|
2025
Q1 | $63.3M | Sell |
627,158
-85,048
| -12% | -$8.56M | 1.1% | 33 |
|
|
2024
Q4 | $63.6M | Sell |
712,206
-24,519
| -3% | -$2.16M | 1.03% | 30 |
|
|
2024
Q3 | $61.7M | Sell |
736,725
-163,900
| -18% | -$12.9M | 1% | 36 |
|
|
2024
Q2 | $69.4M | Sell |
900,625
-214,345
| -19% | -$15.7M | 1.15% | 27 |
|
|
2024
Q1 | $76.4M | Hold |
1,114,970
| – | – | 1.26% | 20 |
|
|
2023
Q4 | $64.5M | Hold |
1,114,970
| – | – | 1.14% | 28 |
|
|
2023
Q3 | $58.9M | Buy |
1,114,970
+300
| +0% | +$15.7K | 1.18% | 22 |
|
|
2023
Q2 | $60.3M | Hold |
1,114,670
| – | – | 1.15% | 25 |
|
|
2023
Q1 | $55.8M | Hold |
1,114,670
| – | – | 1.13% | 24 |
|
|
2022
Q4 | $51.6M | Sell |
1,114,670
-250
| -0% | -$10.8K | 1.1% | 22 |
|
|
2022
Q3 | $43.2M | Hold |
1,114,920
| – | – | 0.99% | 32 |
|
|
2022
Q2 | $41.6M | Sell |
1,114,920
-615
| -0.1% | -$25K | 0.91% | 38 |
|
|
2022
Q1 | $49.4M | Sell |
1,115,535
-6,715
| -0.6% | -$291K | 0.88% | 41 |
|
|
2021
Q4 | $47.7M | Buy |
1,122,250
+270
| +0% | +$11.3K | 0.78% | 52 |
|
|
2021
Q3 | $48.7M | Sell |
1,121,980
-70
| -0% | -$3.1K | 0.86% | 46 |
|
|
2021
Q2 | $48M | Hold |
1,122,050
| – | – | 0.84% | 46 |
|
|
2021
Q1 | $43.4M | Buy |
1,122,050
+56,655
| +5% | +$2.14M | 0.81% | 42 |
|
|
2020
Q4 | $38.3M | Buy |
1,065,395
+97,410
| +10% | +$3.51M | 0.73% | 50 |
|
|
2020
Q3 | $37M | Sell |
967,985
-300
| -0% | -$11.6K | 0.78% | 45 |
|
|
2020
Q2 | $34M | Buy |
968,285
+205
| +0% | +$7.38K | 0.78% | 44 |
|
|
2020
Q1 | $31.6M | Buy |
968,080
+30,195
| +3% | +$1.18M | 0.89% | 39 |
|
|
2019
Q4 | $42.4M | Buy |
937,885
+65
| +0% | +$2.72K | 0.89% | 34 |
|
|
2019
Q3 | $38.2M | Hold |
937,820
| – | – | 0.86% | 37 |
|
|
2019
Q2 | $40.3M | Sell |
937,820
-150
| -0% | -$5.77K | 0.9% | 33 |
|
|
2019
Q1 | $36M | Sell |
937,970
-7,920
| -0.8% | -$302K | 0.85% | 36 |
|
|
2018
Q4 | $33.4M | Hold |
945,890
| – | – | 0.87% | 37 |
|
|
2018
Q3 | $36.4M | Sell |
945,890
-80
| -0% | -$2.79K | 0.8% | 41 |
|
|
2018
Q2 | $30.9M | Buy |
945,970
+100,995
| +12% | +$3.05M | 0.72% | 45 |
|
|
2018
Q1 | $23.1M | Buy |
+844,975
| New | +$23M | 0.52% | 56 |
|
Other funds holding BSX
Nicholas Company's BSX Position: Q2 2026 in Review
Nicholas Company increased its Boston Scientific (BSX) stake by 33% in Q2 2026, buying an estimated $13.1M and bringing the position to 982,444 shares worth $41.9M. The position accounts for 0.77% of the portfolio, ranked #47.
Nicholas Company first reported a position in BSX in Q1 2018 and has held it in 34 quarters since. The position peaked at $76.4M in Q1 2024. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Nicholas Company held 982,444 shares of Boston Scientific worth $41.9M as of Q2 2026.
- Nicholas Company bought 241,170 Boston Scientific shares in Q2 2026, an estimated $13.1M.
- Boston Scientific made up 0.77% of Nicholas Company's portfolio in Q2 2026, its #47 holding.
- Nicholas Company first reported a position in Boston Scientific in Q1 2018 and has held it in 34 quarters since.
- Nicholas Company's Boston Scientific position peaked at $76.4M in Q1 2024.
- 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Nicholas Company's 13F filing for Q2 2026, filed 5 Aug 2026.